Invizyne
About:
Invizyne specializes in enzyme design and the development of cell-free enzymatic pathways.
Website: https://www.invizyne.com/
Top Investors: US Department of Energy, U.S. Department of Defense
Description:
Invizyne specializes in the design of enzymes and the construction of truly cell-free enzymatic pathways that can run continuously and unassisted outside of living cells, avoiding many of the issues that other synthetic biology companies face when attempting to scale cell-based or immobilized biomanufacturing technologies.
Total Funding Amount:
$5.77M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Monrovia, California, United States
Founded Date:
2014-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-11-19
IPO Status:
Public
Industries:
© 2025 bioDAO.ai